The Impact of Small Changes in Bar Closing Hours on Violence. The Norwegian Experience from 18 Cities
Overview
Authors
Affiliations
Aims: To estimate the effect on violence of small changes in closing hours for on-premise alcohol sales, and to assess whether a possible effect is symmetrical.
Design, Setting, And Participants: A quasi-experimental design drawing on data from 18 Norwegian cities that have changed (extended or restricted) the closing hours for on-premise alcohol sales. All changes were ≤ 2 hours.
Measurements: Closing hours were measured in terms of the latest permitted hour of on-premise trading, ranging from 1 a.m. to 3 a.m. The outcome measure comprised police-reported assaults that occurred in the city centre between 10 p.m. and 5 a.m. at weekends. Assaults outside the city centre during the same time window should not be affected by changes in closing hours but function as a proxy for potential confounders, and was thus included as a control variable. The data spanned the period Q1 2000-Q3 2010, yielding 774 observations.
Findings: Outcomes from main analyses suggested that each 1-hour extension of closing hours was associated with a statistically significant increase of 4.8 assaults (95% CI 2.60, 6.99) per 100,000 inhabitants per quarter (i.e. an increase of about 16%). Findings indicate that the effect is symmetrical. These findings were consistent across three different modelling techniques.
Conclusion: In Norway, each additional 1-hour extension to the opening times of premises selling alcohol is associated with a 16% increase in violent crime.
Examination of patients presenting to the emergency department as "apparently drunk".
Hanrahan M, OMahony M, McLoughlin D, Sheahan A Ir J Med Sci. 2025; 194(1):375-384.
PMID: 39821069 PMC: 11861132. DOI: 10.1007/s11845-025-03868-w.
van der Velde L, Shabaan A, Mansson A, Wennberg P, Allebeck P, Karlsson T Eur J Public Health. 2024; 35(1):52-59.
PMID: 39673429 PMC: 11832136. DOI: 10.1093/eurpub/ckae195.
ODonnell R, Mohan A, Purves R, Maani N, Angus C, Egan M Drugs (Abingdon Engl). 2024; 31(3):338-347.
PMID: 38835541 PMC: 11147450. DOI: 10.1080/09687637.2023.2205991.
Eassey C, Hughes C, Wadds P, De Andrade D, Barratt M Harm Reduct J. 2024; 21(1):47.
PMID: 38383344 PMC: 10882826. DOI: 10.1186/s12954-024-00949-4.
Goldman-Mellor S, Qin P EClinicalMedicine. 2024; 68:102442.
PMID: 38333541 PMC: 10850407. DOI: 10.1016/j.eclinm.2024.102442.